Corium to Present at Jefferies 2014 Global Healthcare Conference
MENLO PARK, Calif., May 28, 2014 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple, Corium’s President and Chief Executive Officer, will present on Wednesday, June 4th at the Jefferies 2014 Global Healthcare Conference in New York City at the Grand Hyatt Hotel.

Corium Reports Second Fiscal Quarter 2014 Financial Results
MENLO PARK, Calif., May 13, 2014 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited results from operations for both the second fiscal quarter and the six months ended March 31, 2014.

Corium to Report Second Quarter Fiscal Year 2014 Financial Results on Tuesday, May 13, 2014
MENLO PARK, Calif., May 7, 2014 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI) today announced that it will release second quarter fiscal year 2014 financial results on Tuesday, May 13, 2014 after the close of the U.S. financial markets. Corium will host a conference call and live audio webcast at 5:00 p.m. Eastern time, 2:00 p.m. Pacific time to discuss its financial results.